StockGuru Blog: Medizone (MZEI) – If you like SKVI, you MUST look at MZEI – Different in a lot of ways, but great value stories

STOCKGURU PROFILE FOR MEDIZONE - CORPORATE WEB SITE

Dear Members,

Many of you looking at SKVI know the stock has a great formulation for preventing the spread of viruses for up to four hours, including – most importantly – H1N1. One of our other featured companies that has seen MULTI-YEAR HIGHS since coverage began is MEDIZONE INTERNATIONAL (OTC: MZEI).  Although a Pink Sheet, it is FULLY REPORTING!

I wanted to take a moment to remember longer term members and to introduce the company to newer members.

This company has a revolutionary way to clean hospitals. We are not talking ammonia and a mop. This is their AsepticSure™ technology to sterilize and decontaminate hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure.

They use Ozone. Quoting from our PROFILE:

A Solution:  Ozone is a Prime Candidate for use as a Sterilization Agent in Medical Facilities

Many people do not realize that ozone had a long and successful history of use as a potent anti-bacterial, anti-fungal and anti-viral agent.  Ozone was first used as a disinfectant in 1881 by Dr. Kellog. In 1893 Ozone was used in the Netherlands for water purification. Presently, in excess of 3,000 municipalities around the world use Ozone for water purification.

Research conducted in New York City has also demonstrated that Ozone is effective against Legionella Bacteria, as well as pseudomonas populations in those water purification plants. Ohio State University (2001) demonstrated a 4 log difference in sporicidal action of Ozone vs. Vaporized Hydrogen Peroxide (6.1 log reduction for Ozone vs. 1.6 log reduction for VHP). Microsearch Laboratories has demonstrated (2007) that Ozone is 3,200 times more effective than chlorine. {end quote - CLICK HERE TO SEE STOCKGURU PROFILE}

Please take a moment to read about this company. This technology is cutting edge

VALUATION OF MZEI AND THE CAPITAL STRUCTURE:

At $0.075 it is a BARGAIN.

Let me talk about the capital structure for a moment:

Stock traded for DECADES.

Never a reverse split

Fully reporting Pink Sheet.

No “preferred shares” or any funny convertibles. You get in the market the same preferred shares the directors and management of the company hold.

Recent multi-year high of $0.17 is still way too cheap. Like with SKVI, you ask yourself, what is this worth when it comes to market?

I am not going to put you a ‘target’ my own. I never do that. I can tell you even at the multi-year high of $0.17 it was worth several times more. That is the way I look at it. You have to do your own due diligence. This is one to buy and ignore for six months to a year.

Good luck on it – PLEASE – do look at the profile.

Thank you,

John Pentony

Publisher, StockGuru

STOCKGURU PROFILE FOR MEDIZONE - CORPORATE WEB SITE

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 200,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.